Comparison between Dipna Pharmachem IPO and Jay Jalaram Technologies IPO.
Dipna Pharmachem IPO is a SME Fixed Price IPO proposed to list at BSE SME while Jay Jalaram Technologies IPO is a SME Fixed Price proposed to list at NSE SME.
| Dipna Pharmachem IPO | Jay Jalaram Technologies IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Interactive Financial Services Ltd. | Beeline Capital Advisors Pvt.Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | MUFG Intime India Pvt.Ltd. |
| Market Maker | Sernet Financial Services Pvt.Ltd. | Sunflower Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Dipna Pharmachem IPO is up to ₹14.43 Cr whereas the issue size of the Jay Jalaram Technologies IPO is up to ₹10.26 Cr. The final issue price of Dipna Pharmachem IPO is ₹38.00 per share and of Jay Jalaram Technologies IPO is ₹36.00 per share.
| Dipna Pharmachem IPO | Jay Jalaram Technologies IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹38.00 per share | ₹36.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 3000 shares | 3000 shares |
| Fresh Issue Size | 37,98,000 shares | 28,50,000 shares |
| Fresh Issue Size (Amount) | up to ₹14.43 Cr | up to ₹10.26 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 37,98,000 shares | 28,50,000 shares |
| Issue Size Total (Amount) | up to ₹14.43 Cr | up to ₹10.26 Cr |
Dipna Pharmachem IPO opens on Aug 25, 2022, while Jay Jalaram Technologies IPO opens on Aug 26, 2022. The closing date of Dipna Pharmachem IPO and Jay Jalaram Technologies IPO is Aug 30, 2022, and Aug 30, 2022, respectively.
| Dipna Pharmachem IPO | Jay Jalaram Technologies IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Aug 25, 2022 | Aug 26, 2022 |
| Issue Close | Aug 30, 2022 | Aug 30, 2022 |
| Basis Of Allotment (Tentative) | Sep 05, 2022 | |
| Initiation of Refunds (Tentative) | Sep 06, 2022 | |
| Credit of Share (Tentative) | Sep 07, 2022 | |
| Listing date (Tentative) | Sep 08, 2022 | Sep 08, 2022 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Dipna Pharmachem IPO P/E ratio is 39, as compared to Jay Jalaram Technologies IPO P/E ratio of 46.
| Dipna Pharmachem IPO | Jay Jalaram Technologies IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100 | 100 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 66.56 | 73.04 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 39 | 46 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹45.49 Cr. | ₹40.07 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Dipna Pharmachem IPO Retail Individual Investors (RII) are offered 18,99,000 shares while in Jay Jalaram Technologies IPO retail investors are offered 18,99,000 shares. Qualified Institutional Buyers (QIB) are offered in Dipna Pharmachem IPO and in Jay Jalaram Technologies IPO.
| Dipna Pharmachem IPO | Jay Jalaram Technologies IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | 2,04,000 shares | 1,50,000 shares |
| QIB | ||
| NII | 18,99,000 shares | 14,25,000 shares |
| RII | 18,99,000 shares | 14,25,000 shares |
| Employee | ||
| Others | ||
| Total | 37,98,000 shares | 28,50,000 shares |
Dipna Pharmachem IPO subscribed 2.77x in total, whereas Jay Jalaram Technologies IPO subscribed 14.97x.
| Dipna Pharmachem IPO | Jay Jalaram Technologies IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 0.78x | 18.56x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 4.75x | 11.38x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 2.77x | 14.97x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
